“The trial is meant to define or test this agent in this population for which currently there's not an established standard of care,” says Robert Svatek, MD.
Robert Svatek, MD
Advertisement
Articles by Robert Svatek, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
NDV-01 produces robust 9-month results in high-risk NMIBC
2
SUO 2025 data confirm IsoPSA accuracy independent of mpMRI use
3
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
4
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
5
